Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb:318:70-75.
doi: 10.1016/j.atherosclerosis.2020.11.005. Epub 2020 Nov 11.

Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule

Hiroki Sugane  1 , Yu Kataoka  2 , Fumiyuki Otsuka  3 , Yuriko Nakaoku  4 , Kunihiro Nishimura  4 , Hiroki Nakano  5 , Kota Murai  3 , Satoshi Honda  3 , Hayato Hosoda  6 , Hideo Matama  3 , Takahito Doi  3 , Takahiro Nakashima  3 , Masashi Fujino  3 , Kazuhiro Nakao  3 , Shuichi Yoneda  3 , Yoshio Tahara  3 , Yasuhide Asaumi  3 , Teruo Noguchi  3 , Kazuya Kawai  6 , Satoshi Yasuda  7
Affiliations

Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule

Hiroki Sugane et al. Atherosclerosis. 2021 Feb.

Abstract

Background and aims: Calcified nodule (CN) is an eruptive calcified mass causing acute coronary syndrome (ACS). Since coronary calcification is associated with an elevated cardiac event's risk, ACS attributable to CN may exhibit worse clinical outcome following percutaneous coronary intervention (PCI).

Methods: We retrospectively analyzed 657 ACS patients receiving PCI with newer-generation drug-eluting stent (DES) implantation under intravascular ultrasound (IVUS) guidance. CN was defined as (1) protruding calcification with its irregular surface and (2) the presence of calcification at adjacent proximal and distal segments. The primary endpoint was a composite of major adverse cardiac event [MACE = cardiac death + ACS recurrence + target lesion revascularization (TLR)].

Results: CN was identified in 5.3% (=35/657) of the study subjects. CN patients were more likely to have coronary risk factors including hypertension (p = 0.005), chronic kidney disease (p < 0.001), maintenance hemodialysis (p < 0.001) and a history of PCI (p < 0.001). During the observational period (median = 1304 days), CN was associated with an increased risk of MACE (HR = 7.68, 95%CI = 4.61-12.80, p < 0.001), ACS recurrence (HR = 12.32, 95%CI = 6.05-25.11, p < 0.001) and TLR (HR = 10.48, 95%CI = 5.80-18.94, p < 0.001). These cardiac risks related to CN were consistently observed by Cox proportional hazards model (MACE: p < 0.001, ACS recurrence: p < 0.001, TLR: p < 0.001) and a propensity score-matched cohort analysis (MACE: p = 0.002, ACS recurrence: p = 0.01, TLR: p = 0.005). Of note, over 80% of TLR at the CN lesion was driven by its re-appearance within the implanted DES.

Conclusions: ACS patients attributable to CN have an increased risk of ACS recurrence and TLR, mainly driven by the continuous growth and protrusion of the calcified mass.

Keywords: Acute coronary syndrome; Calcified nodule; In-stent restenosis; Intravascular ultrasound.

PubMed Disclaimer

Comment in

LinkOut - more resources